Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...

The Research Topic will explore emerging technologies such as advanced MRI, fMRI, PET, CT ... Schizophrenia · Stroke · Brain Tumors · Multiple Sclerosis · Parkinson’s Disease · Epilepsy and Seizures · ...

A thorough evaluation including medical history, physical exams, cognitive tests, and brain imaging, such as MRI or CT scans ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.

Brain magnetic resonance imaging (MRI) usage and PPV for subtypes (MSA with parkinsonism [MSA-P] and MSA with cerebellar ...

Molson Coors Beverage Co. Cl B $61.89 1.39 2.30% ...